Literature DB >> 8790072

The role of hypertension in the pathogenesis of heart failure. A clinical mechanistic overview.

R S Vasan1, D Levy.   

Abstract

Hypertension plays a key role in the evolution of the syndrome of heart failure. Hypertension has been identified as the chief precursor of left ventricular hypertrophy. Hypertensive left ventricular hypertrophy can lead to ventricular diastolic dysfunction; it is also a risk factor for myocardial infarction, which is a principal cause of left ventricular systolic dysfunction. Asymptomatic left ventricular dysfunction, whether systolic or diastolic, culminates in clinically overt heart failure when a threshold is exceeded or when other precipitating factors are superimposed. The onset of overt heart failure heralds a bleak outcome. These structural and functional changes associated with hypertension evolve over decades and are preventable with effective antihypertensive treatment. These observations emphasize the importance of early diagnosis and effective treatment of hypertension to prevent cardiac complications.

Entities:  

Mesh:

Year:  1996        PMID: 8790072

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  47 in total

Review 1.  Epidemiology of risk factors for hypertension: implications for prevention and therapy.

Authors:  M Kornitzer; M Dramaix; G De Backer
Journal:  Drugs       Date:  1999-05       Impact factor: 9.546

2.  Uncontrolled hypertension and increased risk for incident heart failure in older adults with hypertension: findings from a propensity-matched prospective population study.

Authors:  Anand S Iyer; Mustafa I Ahmed; Gerasimos S Filippatos; O James Ekundayo; Inmaculada B Aban; Thomas E Love; Navin C Nanda; George L Bakris; Gregg C Fonarow; Wilbert S Aronow; Ali Ahmed
Journal:  J Am Soc Hypertens       Date:  2010 Jan-Feb

3.  Evaluation of systolic and diastolic properties of hypertensive heart failure using speckle-tracking echocardiography with high volume rates.

Authors:  Shingo Minatoguchi; Masanori Kawasaki; Ryuhei Tanaka; Takashi Yoshizane; Koji Ono; Maki Saeki; Maki Nagaya; Hidemaro Sato; Kazuhiko Nishigaki; Toshiyuki Noda; Michael R Zile; Shinya Minatoguchi
Journal:  Heart Vessels       Date:  2017-06-21       Impact factor: 2.037

4.  Vascular risk factors and cognitive impairment in a stroke-free cohort.

Authors:  F W Unverzagt; L A McClure; V G Wadley; N S Jenny; R C Go; M Cushman; B M Kissela; B J Kelley; R Kennedy; C S Moy; V Howard; G Howard
Journal:  Neurology       Date:  2011-11-08       Impact factor: 9.910

5.  The relationship between P wave dispersion and diastolic dysfunction.

Authors:  Huseyin Gunduz; Emrah Binak; Huseyin Arinc; Ramazan Akdemir; Hakan Ozhan; Ali Tamer; Cihangir Uyan
Journal:  Tex Heart Inst J       Date:  2005

Review 6.  Perioperative hypertensive emergencies.

Authors:  Solomon Aronson
Journal:  Curr Hypertens Rep       Date:  2014-07       Impact factor: 5.369

7.  Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy.

Authors:  M Takemoto; K Node; H Nakagami; Y Liao; M Grimm; Y Takemoto; M Kitakaze; J K Liao
Journal:  J Clin Invest       Date:  2001-11       Impact factor: 14.808

8.  Secular trends in echocardiographic left ventricular mass in the community: the Framingham Heart Study.

Authors:  Bernhard M Kaess; Philimon Gona; Martin G Larson; Susan Cheng; Jayashree Aragam; Satish Kenchaiah; Emelia J Benjamin; Ramachandran S Vasan
Journal:  Heart       Date:  2013-09-16       Impact factor: 5.994

9.  Electrocardiographic PR interval and adverse outcomes in older adults: the Health, Aging, and Body Composition study.

Authors:  Jared W Magnani; Na Wang; Kerrie P Nelson; Stephanie Connelly; Rajat Deo; Nicolas Rodondi; Erik B Schelbert; Melissa E Garcia; Caroline L Phillips; Michael G Shlipak; Tamara B Harris; Patrick T Ellinor; Emelia J Benjamin
Journal:  Circ Arrhythm Electrophysiol       Date:  2012-12-16

Review 10.  Heart failure in hypertension: prevention and treatment.

Authors:  Vasiliki V Georgiopoulou; Andreas P Kalogeropoulos; Javed Butler
Journal:  Drugs       Date:  2012-07-09       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.